Analytical Data
-
Gene name
GFUS
- Application
-
Alternative Names
(GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase)(Protein FX)(Red cell NADP(H)-binding protein)(Short-chain dehydrogenase/reductase family 4E member 1)
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13630
-
Expression Region
1-321aa
-
Molecular Weight
40.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on GFUS (growth factor universal superfamily) recombinant proteins has gained significant attention due to their potential therapeutic applications in various fields, including regenerative medicine and cancer therapy. GFUS proteins are known for their roles in cell proliferation, differentiation, and survival, making them crucial in understanding complex biological processes. The ability to produce GFUS proteins through recombinant DNA technology allows for the exploration of their functions at a molecular level and offers a platform for developing novel therapeutic agents. Investigations into the structure-function relationships of GFUS proteins enable scientists to design targeted drugs that can modulate their activity, thus paving the way for innovative treatments of diseases characterized by abnormal growth factor signaling. Additionally, the study of GFUS recombinant proteins contributes to the understanding of cellular responses to external signals and the mechanisms underlying various pathologies. Consequently, the expansion of GFUS protein research is poised to enhance our knowledge of cellular dynamics and foster the development of next-generation biopharmaceuticals.
